Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hilton Food Group trading in line

(Sharecast News) - Hilton Food Group said on Tuesday that current trading was in line with the board's expectations. In an update for the period from 1 January to date ahead of its annual meeting, the company said volumes and sales were ahead of the same period last year across all three operating regions.

In the UK & Ireland, the business continues to outperform the market, benefiting from strong BBQ and Easter trading and despite raw material inflation.

In Europe, meanwhile, the core meat and easier meals businesses continue to perform well, it said, with overall volumes and revenue ahead of last year.

In APAC, volume growth continued, but at more normalised levels versus strong prior year comparatives.

The multi-protein food business also said it continues to make progress toward the planned launches of its long-term partnerships with Walmart in Canada in early 2027 and NADEC in Saudi Arabia in the second half o next year.

"Hilton Foods continues to trade positively, while the macroeconomic environment remains uncertain," it said. "However, in line with market expectations we are confident in our ability to deliver earnings growth for the full year.

"Looking beyond the near term, we are well-positioned for continued growth, supported by our continued investment in a robust pipeline of medium-term growth opportunities in new and existing geographies."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.